CIK 0001360214
- Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450567010
- Phone
- +1 615-733-4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy 10% owner bought 45,000 shares at $3.60 ($162,000)
- 4/A Open-market buy 10% owner bought 45,000 shares at $3.65 ($164,250)
- 4 Open-market buy 10% owner bought 45,000 shares at $3.65 ($164,250)
- 4 Exercise or conversion Chief Financial Officer acquired 15,000 shares (option exercise)
- 4 Grant or award Director acquired 4,573 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 4,469 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 35,000 shares at $7.90 ($276,500)
- 4 Open-market sale 10% owner sold 410,000 shares at an average $8.00 ($3,280,198)
- 4 Open-market buy 10% owner bought 2,801 shares at $8.00 ($22,408)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 6,281 shares (grant or award)
- 4 Grant or award Director acquired 6,281 shares (grant or award)
- 4 Grant or award Director acquired 6,281 shares (grant or award)
- 4 Grant or award Director acquired 6,281 shares (grant or award)
Page 11 of 15 · 296 filings